가정혈압의활용 CARDIOVASCULAR CENTER. Wook Bum Pyun M.D., Ph.D. HOME BLOOD PRESSURE MONITORING. Ewha Womans University, school of Medicine

Size: px
Start display at page:

Download "가정혈압의활용 CARDIOVASCULAR CENTER. Wook Bum Pyun M.D., Ph.D. HOME BLOOD PRESSURE MONITORING. Ewha Womans University, school of Medicine"

Transcription

1 가정혈압의활용 HOME BLOOD PRESSURE MONITORING CARDIOVASCULAR CENTER Wook Bum Pyun M.D., Ph.D. Ewha Womans University, school of Medicine

2

3 Non-Invasive Blood Pressure Measurement

4

5

6

7 5-20% Resistant to drug treatment European Society of Hypertension (ESH)/European Society of Cardiology (ESC) American Society of Hypertension(ASH)/International Society of hypertension(ish) >140/90 despite treatment with three antihypertensive drugs at optimal doses (50% or more of maximal recommended antihypertensive dose) including a diuretic.

8 Diagnosis of Resistant Hypertension Uncontrolled hypertension Exclude Pseudo resistance Identify Reversible lifestyle factors Discontinue Interfering medication Screening For secondary cause Specific therapy Resistant hypertension Optimize non-pharmacologic and pharmacological treatment regimen

9 Possible causes of pseudo-resistant hypertension Improper blood pressure measurement Heavily calcified or atherosclerotic arteries White coat hypertension Poor patient adherence Inadequate drug doses Inadequate drug combinations

10 Is Useful in the management of patients with Resistance Hypertension? American Journal of Hypertension 28(2) February 2015

11 Changing relationship among clinic, home, and ambulatory blood pressure with increasing age J Am Soc Hypertens 2015;9(7):

12 Home BP Monitoring 42% have white coat hypertension on both ambulatory BP monitoring and home BP monitoring (58% discordance) 44% have masked hypertension on both ambulatory BP monitoring and home BP monitoring (56% discordance)

13 HBPM overestimated systolic BP by 8.8 (95% CI = ) mmhg and diastolic BP by 0.2 (95% CI = 1.0 to 1.4) mmhg. The specificity, sensitivity, and positive and negative predictive values of HBPM in detecting controlled ambulatory BP were 91%, 55%, 89%, and 59%. HBPM presented good agreement with ABPM and can be used as a complementary method in the follow-up of resistant hypertensive patients, particularly in those with controlled ambulatory BPs. American Journal of Hypertension 28(2) February 2015

14 White-coat hypertension; benign? Hypertension. 2014;63:

15 Hypertension. 2014;63:

16 Hypertension. 2014;63:

17 ABPM; standard BP measurement method with more data BUT

18

19 Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes In CKD or ESRD, ABPM is superior for mortality prediction In 60 yo, HBPM is as good or better than ABPM for mortality prediction In general population additional BP information regardless of measurement type and HBPM and ABPM are higher in prediction of all cause mortality Integrated Blood Pressure Control 2015:

20 HBPM can improve BP control through its indirect effects on patients. HBPM encourages patient-centered care. Self-monitoring of BP reminds patients of the importance of medication adherence and healthy lifestyle factors. Participating in HBPM alone improved BP control.

21

22

23 일반적으로가정혈압은진료실혈압보다낮다. 가정혈압으로서고혈압은 135/85 mmhg 이상으로정의한다. 고혈압을진단할때가정혈압은 1 주일에 5 일이상, 아침저녁으로 1~3 회씩측정할것을권장한다. 평가할때는첫날측정치를제외한후평균치를사용한다. 아침에는자고일어나서 1 시간이내에, 소변을본후, 고혈압약을복용하기전에측정한다. 저녁에는잠자리에들기전에측정할것을권장한다. 단, 처음고혈압을진단하기위해서는 1 주일동안매일측정한값을사용하는것을권장한다.

24 Home blood pressure monitoring: Australian Expert Consensus Statement

25

26 In Cardiovascular events or mortality HBPM and ABPM resulted in similar outcome measurement standard for BP control insufficient data to determine the benefit of using HBPM

27 Guideline for Home Blood Pressure Monitoring

28

29

30

31

32

33

34

35 HBPM OBPM OBPM Improve BP control and same level of BP control as ABPM Low sensitivity of office BP confirmed to detect optimal BP control defined by HBPM (50%) and ABPM (53.4%) Superior standardization; Night BP and dipping pattern Interfere daily activity and sleep

36 ABPM is Reference Standard For optimal care However, home blood pressure monitoring has better reproducibility. Compared with 24-hour ambulatory blood pressure monitoring, home monitoring is less expensive, much more widely available and provides information about the day-to-day variability of blood pressure.

37 Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension Journal of Hypertension 2015, 33:

38 Home BP monitoring has high specificity, but low sensitivity in the diagnosis of white-coat and masked hypertension, and may therefore behave as a complementary to, but not a replacement of ambulatory BP monitoring. Journal of Hypertension 2015, 33:

39 ABPM Vs. HBPM J Am Soc Hypertens 2016;10(3):

40 There is a lack of strong empiric evidence supporting ABPM or HBPM over the other approach for predicting cardiovascular events or mortality.

41 Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes By comparison, HBPM has some advantages over ABPM. The availability of affordable BP monitoring devices has allowed individuals to measure and record BPs repeatedly throughout their course of treatment. In contrast, ABPM is not directly available to patients, and its high cost presents a barrier to initial and repeated testing. By requiring the individual to wear the cuff and monitor continuously, ABPM does interfere with daily activities and sleep. Although, any advantage in convenience or comfort with HBPM is weighed against the superior standardization of BP measurement and the acquisition of sleep-time BP data by 24-hour ABPM.

42 Blood Pressure Variability; Types and Prognostic Significance Parati G et al. Nature Reviews Cardiology :

43 Wireless HBPM

44 Telemonitoring in the Management of High Blood Pressure Current Pharmaceutical Design, 2015, 21,

45 Telemonitoring Vs. usual care In uncontrolled hypertensive patients To evaluate BP control rate at 6, 12 months At 6 months 71.8% Vs 45.2 (p<0.001) 12 months 71.2% Vs. 52.8% (p=0.005) 18 months 71.8% Vs. 57.1% (p=0.003) Home BP telemonitoring achieved better BP control JAMA 2013;310(1):46-56

46 There is now strong evidence from several randomized controlled trials that using telemetry to communicate home BP measures to healthcare providers (telemonitoring) is associated with highly statistically and clinically significant reductions in BP. However the studies have been of relatively short duration and it is not known if these reductions would be sustained in the long term, nor have any of the studies been at large scale. While there are challenges to implementing telemonitoring at scale there is a need for large implementation trials over relatively prolonged periods to establish the efficacy of such an approach in routine care. Current Pharmaceutical Design, 2015, 21,

47

48 U.S. Prevention Services Task Force Recommendation Statement

49 U.S. Prevention Services Task Force Recommendation Statement

50 An advantage of 24-hour ambulatory blood pressure monitoring is the detection of nocturnal hypertension or non-dipping blood pressure patterns, which are associated with a worse prognosis. However, newer devices for home blood pressure monitoring may enable nocturnal measurements. At this stage the two methods should be considered as complementary clinical tools.

51 Complementary

52 Do you agree?

53 감사합니다.

54

55

Is Traditional Clinic Blood Pressure Dead?

Is Traditional Clinic Blood Pressure Dead? Royal College of Physicans May 16 th 2017 Is Traditional Clinic Blood Pressure Dead? Professor Bryan Williams MD FRCP FAHA FESC Chair of Medicine UCL Director National Institute for Health Research Biomedical

More information

Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair

Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right Anthony J. Viera, MD, MPH, FAHA Professor and Chair Objectives Review limitations of office BP in making a correct diagnosis of hypertension

More information

Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls

Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls Anthony J. Viera, MD, MPH, FAHA Department of Family Medicine Hypertension Research Program UNC School of Medicine Objectives Review limitations

More information

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

Importance of Ambulatory Blood Pressure Monitoring in Adolescents Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud

More information

The Evolution To Treatment Of Hypertension With Advanced Formulation

The Evolution To Treatment Of Hypertension With Advanced Formulation The Evolution To Treatment Of Hypertension With Advanced Formulation Dr. Donald Ang MBChB (UK) FRCP (Edin) MD (UK) CCST Cardiology (UK) FESC (Europe) Consultant Cardiologist Island Hospital Penang High

More information

Hipertensión enmascarada. Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona

Hipertensión enmascarada. Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona Hipertensión enmascarada Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona HTA enmascarada Definición Prevalencia Características clínicas Riesgo derivado Asociación con LOD Progresión

More information

Slide notes: References:

Slide notes: References: 1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory

More information

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate

More information

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive

More information

Hypertension and Cholesterol in the Elderly

Hypertension and Cholesterol in the Elderly Hypertension and Cholesterol in the Elderly Angela Sanford, MD Assistant Professor of Geriatrics Saint Louis University School of Medicine I have no relevant financial disclosures Cushman WC. The burden

More information

ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods

ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,

More information

Use and Interpretation of Home Blood Pressure Monitoring

Use and Interpretation of Home Blood Pressure Monitoring Use and Interpretation of Home Blood Pressure Monitoring BLOOD PRESSURE in year 2015 PARAMETERS TODAY Gianfranco Parati University of Milano-Bicocca & Ospedale S.Luca, IRCCS, Istituto Auxologico Italiano

More information

Prevention of Heart Failure: What s New with Hypertension

Prevention of Heart Failure: What s New with Hypertension Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults

More information

Disclosures. Funding: CIHR, HSF, AIHS, UHF. Research: Novo Nordisk, CVRx, Valencia. Consulting: Valeant

Disclosures. Funding: CIHR, HSF, AIHS, UHF. Research: Novo Nordisk, CVRx, Valencia. Consulting: Valeant Hypertension Update Raj Padwal Associate Professor General Internal Medicine and Clinical Pharmacology Director, Hypertension Clinic University of Alberta Disclosures Funding: CIHR, HSF, AIHS, UHF Research:

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between

More information

Primary hypertension in adults

Primary hypertension in adults Primary hypertension in adults NICE provided the content for this booklet which is independent of any company or product advertised Hypertension Welcome NICE published an updated guideline on the diagnosis

More information

Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations

Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Acta Medica Marisiensis 2016;62(3):350-355 DOI: 10.1515/amma-2016-0038 UPDATE Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Mako Katalin *, Ureche Corina, Jeremias Zsuzsanna University

More information

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step

More information

Received 24 February 2015 Revised 29 April 2015 Accepted 20 May 2015

Received 24 February 2015 Revised 29 April 2015 Accepted 20 May 2015 Original article 1 Clinical practice of ambulatory versus home blood pressure monitoring in hypertensive patients Jorge A. Paolasso, Florencia Crespo, Viviana Arias, Eduardo A. Moreyra, Ariel Volmaro,

More information

1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany

1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany Page 1 of 9 Validation of the TONOPORT VI ambulatory blood pressure monitor, according to the European Society of Hypertension International Protocol revision 2010 Michael Abou-Dakn 1, Cornelius Döhmen

More information

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult

More information

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION. Dr Diana R Holdright MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION www.drholdright.co.uk Blood pressure is the pressure exerted on the walls of the arteries when the heart pumps;

More information

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical

More information

STATE OF THE ART BP ASSESSMENT

STATE OF THE ART BP ASSESSMENT STATE OF THE ART BP ASSESSMENT PROFESSOR MOLECULAR PHARMACOLOGY CONWAY INSTITUE UNIVERSITY COLLEGE DUBLIN CO-CHAIRMAN BLOOD PRESCSURE MANAGEMENT IN LOW RESOURCE SETTINGS CENTRE FOR INTERNATIONAL HUMANITARIAN

More information

Home Blood Pressure Monitoring Pamphlet

Home Blood Pressure Monitoring Pamphlet University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Home Blood Pressure Monitoring Pamphlet Isobel Ycasas Santos University of Vermont College

More information

BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN?

BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN? BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN? DECLARATION OF INTEREST Medical Director and Chairman, Advisory Board dabl Ltd., Dublin, Ireland. BLOOD PRESSURE MEASUREMENT

More information

Blood Pressure Monitoring in Chronic Kidney Disease

Blood Pressure Monitoring in Chronic Kidney Disease Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American

More information

HYPERTENSION: ARE WE GOING TOO LOW?

HYPERTENSION: ARE WE GOING TOO LOW? HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA

More information

Egyptian Hypertension Guidelines

Egyptian Hypertension Guidelines Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich

More information

Objectives. Describe results and implications of recent landmark hypertension trials

Objectives. Describe results and implications of recent landmark hypertension trials Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships

More information

Self-measured blood pressure monitoring (SMBP)

Self-measured blood pressure monitoring (SMBP) Self-measured blood pressure monitoring (SMBP) Michael Rakotz, MD, FAHA FAAFP Vice President, Improving Health Outcomes, American Medical Association Assistant Clinical Professor, Department of Family

More information

Current strategies for managing hypertension

Current strategies for managing hypertension Eπίκαιρο Άρθρο Ambulatory blood pressure monitoring: the gold standard for the diagnosis and management of hypertension in general practice Eoin O Brien ABSTRACT Although ambulatory blood pressure measurement

More information

5.2 Key priorities for implementation

5.2 Key priorities for implementation 5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail

More information

RESISTANT HYPERTENSION

RESISTANT HYPERTENSION RESISTANT HYPERTENSION John D. Bisognano, MD PhD Professor of Medicine / Cardiology President-Elect, American Society of Hypertension Director, Outpatient Cardiology University of Rochester RESISTANT HYPERTENSION

More information

CLINICAL INFORMATION. RESPeRATE HIGHLIGHTS PROVEN EFFICACY

CLINICAL INFORMATION. RESPeRATE HIGHLIGHTS PROVEN EFFICACY CLINICAL INFORMATION RESPeRATE HIGHLIGHTS RESPeRATE, the world s only FDA-cleared, non-drug, non-invasive device to treat hypertension. Used by over 250,000 patients and physicians, it is recommended by

More information

Patrick Kay, General and Interventional Cardiologist Auckland or healthpoint.co.nz

Patrick Kay, General and Interventional Cardiologist Auckland or healthpoint.co.nz Patrick Kay, General and Interventional Cardiologist Auckland ipatkay@hotmail.com or healthpoint.co.nz Rotorua 2015 Rotorua 2015 Graphical example of true mean and variation, and of regression to the

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Hypertension Evaluation and Management

Hypertension Evaluation and Management Hypertension Evaluation and Management ü Identify High Blood Pressure ü Reduce Salt ü Personalize BP Target Erica S. Spatz, MD, MHS Assistant Professor, Cardiovascular Medicine Center for Outcomes Research

More information

Ambulatory blood pressure monitoring is key to improving hypertension diagnosis

Ambulatory blood pressure monitoring is key to improving hypertension diagnosis Earn 2 CEU Points online Ambulatory blood pressure monitoring is key to improving hypertension diagnosis Professor Bryan Williams Director of the UCL Biomedical Research Centre University College London

More information

White coat and masked hypertension

White coat and masked hypertension White coat and masked hypertension Conflict of interest Support from Spacelabs, Microlife. Honoraria from Novartis, Elpen, Boeringer-Ingelheim, CANA, Lilly, MSD, Sanofi, Menarini, Ciezi, Astra-Zeneca.

More information

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment

More information

Hypertension Clinical case scenarios for primary care

Hypertension Clinical case scenarios for primary care Hypertension Clinical case scenarios for primary care Implementing NICE guidance August 2011 NICE clinical guideline 127 What this presentation covers Five clinical case scenarios, including: presentation

More information

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension (2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers

More information

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine

More information

USM Digital Commons. University of Southern Maine. Elizabeth Andrews University of Southern Maine

USM Digital Commons. University of Southern Maine. Elizabeth Andrews University of Southern Maine University of Southern Maine USM Digital Commons Muskie School Capstones Student Scholarship 4-13-2014 Blood pressure monitoring of hypertensive patients in primary care: barriers and facilitators to ambulatory,

More information

KDIGO Controversies Conference on Blood Pressure in CKD

KDIGO Controversies Conference on Blood Pressure in CKD KDIGO Controversies Conference on Blood Pressure in CKD September 7-10, 2017 Edinburgh, Scotland Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization whose mission is to improve

More information

Hypertension and Cardiovascular Disease

Hypertension and Cardiovascular Disease Hypertension and Cardiovascular Disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,

More information

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

University of Padova, Padua, Italy, and HARVEST Study Group, Italy University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini

More information

Clinical Medical Policy Department Clinical Affairs Division DESCRIPTION

Clinical Medical Policy Department Clinical Affairs Division DESCRIPTION Ambulatory Blood Pressure Monitoring (ABPM) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr. go to Comunicados a Proveedores, and click Cartas Circulares.]

More information

Treating hypertension in kidney transplant recipients

Treating hypertension in kidney transplant recipients Treating hypertension in kidney transplant recipients Mark Mitsnefes, MD, MS Professor of Pediatrics Director, Clinical Translational Research Center Cincinnati Children s Hospital Medical Center University

More information

AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston

AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK Michael Smolensky, Ph.D. The University of Texas Austin & Houston Disclosures Partner: Circadian Ambulatory Diagnostics Consultant: Spot On Sciences

More information

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

AFFORDABLE TECHNOLOGY

AFFORDABLE TECHNOLOGY World Health Organization AFFORDABLE TECHNOLOGY BLOOD PRESSURE MEASURING DEVICES FOR LOW RESOURCE SETTINGS CARDIOVASCULAR DISEASES Blood Pressure Measurement in Low Resource Settings Annex 1: Blood Pressure

More information

This article will focus on the role of the following in BP management and their prognostic significance:

This article will focus on the role of the following in BP management and their prognostic significance: CARDIOVASCULAR DISORDERS UNIT NO. 2 HOME BLOOD PRESSURE MONITORING, BLOOD PRESSURE VARIABILITY AND MORNING BLOOD PRESSURE SURGE Dr Rohit Khurana, Dr Lucy Priestner ABSTRACT Hypertension is a common chronic

More information

Blood pressure treatment target in diabetes. Should it be <130 mmhg?

Blood pressure treatment target in diabetes. Should it be <130 mmhg? Blood pressure treatment target in diabetes Should it be

More information

MPharmProgramme. Hypertension (HTN)

MPharmProgramme. Hypertension (HTN) MPharmProgramme Hypertension (HTN) Slide 1 of 30 Overview Definition Prevalence Type Causes Diagnosis Management Patients perspective Slide 2 of 30 Definition It is not a disease! So what is it? What two

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

Management of High Blood Pressure in Children and Adolescents

Management of High Blood Pressure in Children and Adolescents Π.Μ.Σ. «ΜΟΝΑΔΕΣ ΕΝΤΑΤΙΚΗΣ ΘΕΡΑΠΕΙΑΣ - ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣΗΛΕΥΤΙΚΗ» Management of High Blood Pressure in Children and Adolescents ΕΠΙΔΡΑΣΗ ΤΗΣ ΑΝΤΙΥΠΕΡΤΑΣΙΚΗΣ ΑΓΩΓΗΣ ΣΤΗΝ ΑΡΤΗΡΙΑΚΗ ΣΚΛΗΡΙΑ ΥΠΕΡΤΑΣΙΚΩΝ ΑΣΘΕΝΩΝ

More information

HTN talk_l Davis_ /28/2018

HTN talk_l Davis_ /28/2018 1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,

More information

Chapter 2 Home (Self) Monitoring of Blood Pressure

Chapter 2 Home (Self) Monitoring of Blood Pressure Chapter 2 Home (Self) Monitoring of Blood Pressure Gianfranco Parati and Juan Eugenio Ochoa Introduction Elevated blood pressure (BP) levels represent the most important modifiable risk factor for cardiovascular

More information

Adherence to Hypertension Visit Protocol Description: % of patients with HTN who are being monitored through follow up visits according to guidelines, based on "days since last BP", which looks back from

More information

Update on HTN and ABPM. Raj Padwal Division of General Internal Medicine University of Alberta

Update on HTN and ABPM. Raj Padwal Division of General Internal Medicine University of Alberta Update on HTN and ABPM Raj Padwal Division of General Internal Medicine University of Alberta Disclosures Funding: CIHR, AIHS, HSF, UHF Research Collaboration: Novo Nordisk, CVRx Consulting: Vivus, Medtronic

More information

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure 신장환자의혈압조절 K/DOQI Clinical practice guidelines on Hypertension and Antihypertensive agents in CKD 나기영 Factors involved in the regulation of blood pressure Renal function curve MAP (mmhg) Central role of

More information

OHTAC Recommendation: Twenty-Four-Hour Ambulatory Blood Pressure Monitoring in Hypertension. Ontario Health Technology Advisory Committee

OHTAC Recommendation: Twenty-Four-Hour Ambulatory Blood Pressure Monitoring in Hypertension. Ontario Health Technology Advisory Committee OHTAC Recommendation: Twenty-Four-Hour Ambulatory Blood Pressure Monitoring in Hypertension Ontario Health Technology Advisory Committee May 2012 Background Hypertension in Canada Hypertension occurs when

More information

Impact of Recent Hypertension Guidelines on Clinical Practice

Impact of Recent Hypertension Guidelines on Clinical Practice C H A P T E R 144 Impact of Recent Hypertension Guidelines on Clinical Practice NK Soni, VB Jindal The movement towards evidence-based healthcare has been gaining ground quickly over the past few years,

More information

Hypertension Putting the Guidelines into Practice

Hypertension Putting the Guidelines into Practice Hypertension 2017 Putting the Guidelines into Practice Disclosures Relationships with commercial interests: Grants/Research Support: Speakers Bureau/Honoraria: Consulting Fees: Data Safety and Monitoring:

More information

Ambulatory Blood Pressure Monitoring for the Effective Management of Antihypertensive Drug Treatment

Ambulatory Blood Pressure Monitoring for the Effective Management of Antihypertensive Drug Treatment Clinical Therapeutics/Volume 38, Number 1, 216 Review Article Ambulatory Blood Pressure Monitoring for the Effective Management of Antihypertensive Drug Treatment Eoin O Brien, DSc, MD 1 ; and Eamon Dolan,

More information

Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients?

Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients? O R I G I N A L A R T I C L E Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients? I. Aksoy, J. Deinum, J.W.M. Lenders, Th. Thien *# Department of

More information

& Wilkins. a Division of Cardiology, Schulich Heart Centre, b Institute for Clinical and

& Wilkins. a Division of Cardiology, Schulich Heart Centre, b Institute for Clinical and Original article 333 Optimum frequency of office blood pressure measurement using an automated sphygmomanometer Martin G. Myers a, Miguel Valdivieso a and Alexander Kiss b,c Objective To determine the

More information

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose. JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I

More information

Hypertension Pharmacotherapy: A Practical Approach

Hypertension Pharmacotherapy: A Practical Approach Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.

More information

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. Devices and technology 261 Validation of the ROSSMAX blood pressure measuring monitor according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring

More information

Running head: HYPERTENSION MANAGEMENT WITH HBPM

Running head: HYPERTENSION MANAGEMENT WITH HBPM Running head: HYPERTENSION MANAGEMENT WITH HBPM Implementing a Home-Based Blood Pressure Monitoring Program to Improve Hypertension Management By: Nicole Bello, MSN, APRN, FNP-C Georgia College & State

More information

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing

More information

ERKAMETER 24 The expert in medical diagnostics

ERKAMETER 24 The expert in medical diagnostics ERKAMETER 24 The expert in medical diagnostics Erkameter 24 - highly accurate multifunctional diagnostic device allowing to define optimal therapy goals The diagnosis of hypertension is usually made by

More information

Φαρµακευτική θεραπεία υπερτασικών ασθενών. Δ. Τσιαχρής, Καρδιολόγος, Α Πανεπιστηµαική Καρδιολογική Κλινική

Φαρµακευτική θεραπεία υπερτασικών ασθενών. Δ. Τσιαχρής, Καρδιολόγος, Α Πανεπιστηµαική Καρδιολογική Κλινική Φαρµακευτική θεραπεία υπερτασικών ασθενών Δ. Τσιαχρής, Καρδιολόγος, Α Πανεπιστηµαική Καρδιολογική Κλινική A 42-Year-Old Female with True Severe Resistant Hypertension Female, 42 years old, smoker BMI:

More information

Ambulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease. Rajiv Agarwal, MD

Ambulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease. Rajiv Agarwal, MD Ambulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease Rajiv Agarwal, MD Summary: Hypertension is an important risk factor for adverse cardiovascular and renal outcomes, particularly

More information

Blood Pressure LIMBO How Low To Go?

Blood Pressure LIMBO How Low To Go? Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity

More information

Hypertension: Global Burden & Barriers

Hypertension: Global Burden & Barriers Hypertension: Global Burden & Barriers A/Prof Clara Chow The George Institute, University of Sydney Dept. of Cardiology, Westmead Hospital Affiliated with the University of Sydney Dr Chow is supported

More information

hypertension Head of prevention and control of CVD disease office Ministry of heath

hypertension Head of prevention and control of CVD disease office Ministry of heath hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension

More information

Combination Therapy for Hypertension

Combination Therapy for Hypertension Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP

More information

Comparison of arbitrary definitions of circadian time periods with those determined by wrist actigraphy in analysis of ABPM data

Comparison of arbitrary definitions of circadian time periods with those determined by wrist actigraphy in analysis of ABPM data Journal of Human Hypertension (1999) 13, 449 453 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Comparison of arbitrary definitions of

More information

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical

More information

Christian Daugaard Peters, MD, PhD Department of Renal Medicine Aarhus University Hospital, Denmark Disclosures: None

Christian Daugaard Peters, MD, PhD Department of Renal Medicine Aarhus University Hospital, Denmark Disclosures: None The effect of renal denervation on central blood pressure and arterial stiffness in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET

More information

The accurate measurement of blood pressure

The accurate measurement of blood pressure Position Paper ASH Position Paper: Home and Ambulatory Blood Pressure Monitoring When and How to Use Self (Home) and Ambulatory Blood Pressure Monitoring Thomas G. Pickering, MD, D Phil; 1 William B. White,

More information

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,

More information

Summary of recommendations

Summary of recommendations Summary of recommendations Measuring blood pressure (BP) Use the recommended technique at every BP reading to ensure accurate measurements and avoid common errs. Pay particular attention to the following:

More information

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice (2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Hypertension QOF indicator area: Hypertension Date: July 2013

More information

Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN

Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups Lisa Ivy APRN The 2017 Guideline is an Update to JNC7 New information regarding BP related risk of CVD Ambulatory BP monitoring

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart

More information

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

Hypertension Guidelines 2017

Hypertension Guidelines 2017 Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,

More information

CVD Risk of Hypertension. Regina Giblin CVD Clinical Development Coordinator

CVD Risk of Hypertension. Regina Giblin CVD Clinical Development Coordinator CVD Risk of Hypertension Regina Giblin CVD Clinical Development Coordinator CVD Clinical Development Coordinator In-house education for your team: Regina Giblin giblinr@bhf.org.uk Often interactive with

More information